Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma

NCT03996408 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cholangiocarcinoma

Interventions

DRUG: Anlotinib
DRUG: TQB2450

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.